Revvity, Inc. has officially been launched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. The company was previously affiliated with PerkinElmer, Inc.

The company’s comprehensive scientific software platform, previously known as PerkinElmer Informatics, will become Revvity Signals Software, Inc. Revvity Omics replaces PerkinElmer Genomics as the company's genomics services business.

Cisbio, Horizon Discovery, Nexcelom Bioscience, Omni International, Oxford Immunotec, SIRION Biotech and SonoVol will now identify as Revvity, while maintaining their specific product names.

Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech, diagnostic labs, academia and government agencies. “We’re a translational company in the sense that our capabilities facilitate decision making between research and clinical customers,” said Prahlad Singh, President and Chief Executive Officer of Revvity.

“With cross-business collaborations between our automation, multi-omics offerings, and our Signals software business, we have unique capabilities which put us in an optimal position to accelerate breakthrough solutions – starting with preclinical research and scientific discovery, all the way through to diagnosing and helping to treat disease”, he added.